Dr. Christoph Zindel

Member of the Supervisory Board since: 2024, elected until 2028

Year of birth: 1961
Nationality: German
Professional qualification: Dr. med.

Committees

Member of:

• Innovation Committee
• Mediation Committee

Relevant Knowledge, Skills and Experience

Dr. Zindel has been a member of the Supervisory Board of Fresenius SE & Co. KGaA since May 2022. Previously, Dr. Zindel was a member of the Board of Management of Siemens Healthineers AG from October 2019 to March 2022. In 2018-2019 he was managing director of the company's Diagnostic Imaging division and from 2015 to 2018 he headed the Magnetic Resonance Imaging (MRI) unit. From 2012 to 2015, Dr. Zindel worked in the USA. He worked for Siemens Medical Solutions as CEO of PETNET after previously managing the hematology and urinalysis divisions for Beckmann-Coulter. He started his career as a practicing physician in surgery, internal medicine and nuclear medicine. In 1998, he moved to the healthcare industry as a segment manager at Siemens Healthcare and subsequently moved to various senior positions in the magnetic resonance imaging division.

Membership of other Supervisory Boards

Membership of Supervisory Boards according to German legal regulations:

• Fresenius SE & Co. KGaA (listed)

Memberships on similar domestic or foreign control boards of business enterprises:

• none
   

Other significant activities alongside Supervisory Board position:

• Member of the Board of Trustees of the Fraunhofer Heinrich Hertz Institute
• Member of the advisory board of LifeLink Medical GmbH